Shots: The P-III JAVELIN Head and Neck 100 study involve assessing of Bavencio (avelumab) + CRT followed by avelumab maintenance vs CRT alone in 697 patients with previously untreated LA […]readmore
Tags : Squamous Cell Carcinoma of the Head and Neck